{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:17:48Z","timestamp":1790511468616,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jaad.2013.09.007","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T09:11:39Z","timestamp":1389777099000},"page":"374-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Large-cell transformation of mycosis fungoides\u2013differential diagnosis with implications for clinical management: A consensus statement of the US Cutaneous Lymphoma Consortium"],"prefix":"10.1016","volume":"70","author":[{"given":"Marshall E.","family":"Kadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren C.","family":"Hughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.09.007_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib2","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathologic and prognostic features of 45 cases","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib3","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib4","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib5","series-title":"World Health Organization classification of tumors","first-page":"300","article-title":"Primary cutaneous CD30-positive T-cell lymphoproliferative disorders","author":"Ralfkiaer","year":"2008"},{"key":"10.1016\/j.jaad.2013.09.007_bib6","first-page":"1158","article-title":"Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders","volume":"23","author":"Kadin","year":"2009","journal-title":"Oncology (Williston Park)"},{"issue":"Suppl","key":"10.1016\/j.jaad.2013.09.007_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0303-6987.2006.00507.x","article-title":"Pathobiology of CD30+ cutaneous T-cell lymphomas","volume":"33","author":"Kadin","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2013.09.007_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/S\u00e9zary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib10","unstructured":"Krathen RA, Bashey S, Salma K, Wood G, Sudram U, Nagpal S, et\u00a0al. Brentuximab vedotin demonstrates clinical activity in mycosis fungoides (MF) and S\u00e9zary syndrome (SS) irrespective of tissue CD30 expression by routine immunohistochemistry. In: TLOC International Program Committee, MCI Deutschland GmbhH, Berlin, editor. Second World Congress of Cutaneous Lymphomas. Berlin: The International Program Committee, Local Organizing Committee; 2013. p. 088."},{"key":"10.1016\/j.jaad.2013.09.007_bib11","first-page":"086","article-title":"Phase II trial of brentuximab vedotin (SGN-35) for CD30+ cutaneous T-cell lymphomas and lymphoproliferative disorders","author":"Duvic","year":"2013"},{"key":"10.1016\/j.jaad.2013.09.007_bib12","unstructured":"Fauconneau A, Pham-Ledard A-L, Vergier B, Parrens M, Frison E, Merlio JP, et\u00a0al. Primary cutaneous anaplastic large cell lymphoma and CD30+ large cell transformed mycosis fungoides: comparative study of 81 cases. In: TLOC International Program Committee, MCI Deutschland GmbhH, Berlin, editor. Second World Congress of Cutaneous Lymphomas. Berlin: The International Program Committee, Local Organizing Committee; 2013. p. 029."},{"key":"10.1016\/j.jaad.2013.09.007_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2013.09.007_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2013.09.007_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.09.007_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1600-0625.2012.01548.x","article-title":"Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides","volume":"21","author":"Benner","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.09.007_bib17","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V87.8.3437.bloodjournal8783437","article-title":"The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin","volume":"87","author":"DeCoteau","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.007_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e3181648d6d","article-title":"Primary cutaneous ALCL with phosphorylated\/activated cytoplasmic ALK and novel phenotype: EMA\/MUC1+, cutaneous lymphocyte antigen negative","volume":"32","author":"Kadin","year":"2008","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:29Z","timestamp":1759271429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213009584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0190962213009584"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.007","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Large-cell transformation of mycosis fungoides\u2013differential diagnosis with implications for clinical management: A consensus statement of the US Cutaneous Lymphoma Consortium","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}